IQVIA (NYSE: IQV) director granted 171 deferred shares at $178.64

Rhea-AI Filing Summary

Wims Morris Leslie reported acquisition or exercise transactions in this Form 4 filing.

IQVIA Holdings Inc. director Morris Leslie Wims received an award of 171 deferred shares on May 7, 2026. The grant is recorded at a reference price of $178.64 per share and increases his directly held deferred share balance to 6,636 deferred shares.

Each deferred share is convertible into one share of IQVIA common stock upon settlement under the company’s Non-Employee Director Deferral Plan. The deferred shares become settleable when he ceases to be a director, upon a change in control of the company, or upon his death, and there is no expiry date on this award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wims Morris Leslie

Role null

Type	Security	Shares	Price	Value
Grant/Award	Deferred Shares	171	$178.64	$31K

Holdings After Transaction: Deferred Shares — 6,636 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Deferred shares granted: 171 deferred shares Grant reference price: $178.64 per share Deferred shares after transaction: 6,636 deferred shares +1 more

4 metrics

Deferred shares granted 171 deferred shares Grant/award acquisition on May 7, 2026

Grant reference price $178.64 per share Reported transaction price for deferred share award

Deferred shares after transaction 6,636 deferred shares Total directly held deferred shares following award

Conversion ratio 1:1 into common stock Each deferred share converts into one IQVIA common share upon settlement

Key Terms

Deferred Shares, Non-Employee Director Deferral Plan, change in control, derivative

4 terms

Deferred Shares financial

"Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc."

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Non-Employee Director Deferral Plan financial

"The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director"

change in control financial

"The deferred shares become settleable ... upon a change in control of the Company, or upon death of the reporting person."

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

derivative financial

"transaction_type": "derivative","transaction_shares": "171.0000""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wims Morris Leslie

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NORTH CAROLINA 27703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	(1)	05/07/2026		A		171		(1)	(1)	Common Stock	171	$178.64	6,636	D

Explanation of Responses:

1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Remarks:

	/s/Matthew Gilmartin, Attorney-in-Fact for Leslie Wims Morris	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did IQV director Morris Leslie Wims report?

Morris Leslie Wims reported receiving 171 deferred shares of IQVIA Holdings Inc. as a grant. These are compensation-related derivative securities, not an open-market purchase, and increase his total directly held deferred share balance to 6,636 deferred shares.

At what reference price were the IQVIA deferred shares granted to Morris Wims?

The 171 deferred shares granted to Morris Leslie Wims were recorded at a reference price of $178.64 per share. This price is used for reporting purposes in the insider filing and does not represent an open-market trade.

How many IQVIA deferred shares does Morris Wims hold after this grant?

After this grant, Morris Leslie Wims holds a total of 6,636 deferred shares of IQVIA Holdings Inc. These deferred shares are a form of director compensation and are convertible into common stock upon settlement events defined in the plan.

When do the IQVIA deferred shares granted to Morris Wims become payable?

The deferred shares become settleable when Morris Leslie Wims ceases to be a director, upon a change in control of IQVIA Holdings Inc., or upon his death. Settlement is governed by the company’s Non-Employee Director Deferral Plan.

How are IQVIA deferred shares held by Morris Wims converted into common stock?

Each deferred share held by Morris Leslie Wims converts into one share of IQVIA common stock upon settlement. Settlement timing follows the Non-Employee Director Deferral Plan, which ties conversion to director service ending, change in control, or death.

Do the IQVIA deferred shares granted to Morris Wims have an expiration date?

The deferred shares granted to Morris Leslie Wims do not have an expiry date. They remain outstanding until a settlement event defined in the Non-Employee Director Deferral Plan occurs, such as end of board service, change in control, or death.